Americas vs Andorra: Proportion of the target population who received a 3rd dose of
Americas
79.0%
in 2024
Andorra
96.0%
in 2024
Americas rank
14th
Andorra rank
16th
Proportion of the target population who received a 3rd dose of over time
- Americas
- Andorra
How they compare
Andorra currently reports 96.0% against 79.0% in Americas, a difference of 17.0%.
That makes Andorra's figure about 1.2 times Americas's.
Across all 11 years both countries report, Andorra has been ahead every year.
Americas ranks 14th and Andorra ranks 16th of 37 groups.
Andorra has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Americas | Andorra | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 82.5% | 94.2% | 11.7% | Andorra |
| 2020s | 76.4% | 95.2% | 18.8% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Americas or Andorra?
- Andorra, at 96.0% against 79.0% in Americas as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Americas and Andorra?
- 17.0%, with Andorra ahead.
- How many years of comparable data are there for Americas and Andorra?
- 11 years are reported by both, from 2014 to 2024.
- How do Americas and Andorra rank globally for proportion of the target population who received a 3rd dose of?
- Americas ranks 14th and Andorra ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.